Jose Merino (Hospital General Universitario La Paz, Madrid) discusses recent advances in technology to improve complex ablation success rates for atrial fibrillation (AF) and/or ventricular tachycardia (VT), including new imaging techniques, and unmet needs relating to complex ablation for AF/VT, including the need for more accurate maps to target lesions and better integration of new imaging techniques with the mapping system currently in use on a daily basis. Dr Merino also highlights the current recurrence rates for AF and/or VT following complex ablation, but explains that this will improve with the advent of new techniques and new technologies in balloons and catheters. He also describes the key components of a successful complex ablation procedure.
Filmed at EHRA 2018, Barcelona.
1. How have recent advances in technology improved complex ablation success rates for atrial fibrillation (AF) and/or ventricular tachycardia (VT)? 0:07
2. What are the unmet needs or clinical challenges relating to complex ablation for AF and/or VT? 1:10
3. What are the current recurrence rates for AF and/or VT following complex ablation? 2:15
4. Please can you describe the key components of a successful complex ablation procedure? 3:19
Share this Video
Related Videos In Interventional Cardiology
David Keane, AF Symposium 2021: Challenges in Catheter Ablation
We spoke to Professor David Keane (St Vincent’s University Hospital, Dublin, Ireland) about the current challenges procedural duration and overall success in catheter ablation, and the most exciting innovations to aim to overcome these. Questions: What are the current challenges in catheter ablation in terms of procedural duration and overall success? (0.13) What are the […]
David Keane, AF Symposium 2021: Atrial Fibrillation in Patients with Hypertrophic Cardiomyopathy
We spoke to Professor David Keane (St Vincent’s University Hospital, Dublin, Ireland) about atrial fibrillation in patients with hypertrophic cardiomyopathy. Questions: What is the incidence of atrial fibrillation (AF) in people with hypertrophic cardiomyopathy (HCM)? (0.13) What is known about the efficacy and safety of catheter ablation of AF in patients with HCM compared to […]
Andrea Natale, AF Symposium 2021: Impact of Catheter Ablation on Quality of Life and Health Care Utilization
We spoke to Dr Andrea Natale (Texas Cardiac Arrhythmia Institute, Austin, TX, USA) about the most exciting recent innovations in catheter ablation technology. Questions: What is the impact of atrial fibrillation (AF) ablation on healthcare utilization and quality of life? (0.13) How should these data influence the timing of ablation strategies? (2.40) Speaker disclosures: Dr […]
Journal articles and more to your inbox
Get the latest clinical insights from touchCARDIOSign me up!